Liu, Yan-ping
Hu, Ming-hui
Lin, Ping-ping
Li, Ting
Liu, Shu-qin
Wang, Yu-ya
Li, Shao-rong
Li, Xiang-kun
Wang, Chen-jing
Funding for this research was provided by:
National Major Science and Technology Projects of China (2020ZX09201-018)
Natural Science Foundation of Shandong Province (ZR2019MH101)
Article History
Accepted: 19 April 2022
First Online: 30 May 2022
Declarations
:
: This work was supported by grants from the National Major Scientific and Technological Special Project for “Significant New Drugs Development” (2020ZX09201-018) and the Natural Science Foundation of Shandong Province, with the grant number ZR2019MH101.
: The authors have no relevant affiliations or financial involvement with any organization or entity with a financial interest in, or financial conflict with, the subject matter or materials discussed in the manuscript. This includes employment, consultancies, honoraria, stock ownership or options, expert testimony, grants or patents received or pending, or royalties. Peer reviewers on this manuscript have no relevant financial or other relationships to disclose.
: The protocol of this clinical study was approved and authorized by the Ethics Committee of the Clinical Research Institute of the Qingdao University Hospital (Qingdao, China).
: All recruited volunteers agreed and provided written informed consent before the study was initiated.
: All authors approved the publication of this manuscript.
: The data is unavailable for confidentiality reasons.
: Not applicable.
: The authors are solely responsible for the design and conduct of this study. Yan-ping LIU, Ming-hui HU, Chen-jing Wang and Yu CAO performed a review of the topic, and wrote and revised the manuscript. Ping-ping LIN, Ting LI and Shu-qin LIU took part in analyzing pharmacokinetics data. Yu-ya WANG, Shao-rong LI and Xiang-kun LI took part in the analysis and interpretation of data, and prepared all figures and tables. All the authors approved the final version of the manuscript.